Kura Oncology's Reverse Merger Round

Kura Oncology raised a round of funding on March 12, 2015. Investors include Zeta Acquisition Corp III.

Kura Oncology is a clinical-stage biopharmaceutical company, creating personalized therapeutics for patients with cancer. The company's pipeline consists of four potent and selective small molecule dr…

Articles about Kura Oncology's Reverse Merger Round: